Another Indian pharma manufacturer in news after WHO's substandard medicine alert

The alert was issued for a batch of substandard (contaminated) Guaifenesin Syrup TG Syrup. The substandard product was identified in the Marshall Islands and Micronesia and reported to WHO on 6 April 2023, a WHO statement said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news